80021075: (EM) Current Topics in Gastrointestinal and Liver Pathology

To purchase this DVD series please visit:
http://www.cmeinfo.com

Program Description

There is a need in the community for up-to-date education in GI pathology as the number of endoscopic procedures has increased since Medicare began to cover colonoscopy. This CME activity on DVD is based on lectures presented at the Johns Hopkins Eighth Annual Conference on Gastrointestinal and Liver Pathology, held November 8-9, 2008. This DVD series is intended as a practical overview for pathologtists who encounter gastrointestinal specimens in daily practice. Interpretation of mucosal biopsies of the upper GI tract are addressed, as well as recent advances in pancreatic pathology. After completing the lectures, participants will come away with a better understanding of interpretation of mucosal biopsies, liver biopsies, pancreatic/biliary disorders and the application of modern techniques to gastrointestinal disorders.

TARGET AUDIENCE

This activity is intended for pathologists.

OBJECTIVES

After attending this activity, participants will be able to:

• Discuss the classification of colitis-associated dysplasia
• Identify common pitfalls in the evaluation of esophageal biopsies
• List critical issues involved in colon cancer staging
• Recognize the differential diagnostic work-up of gastric and small bowel entities
• Define common pitfalls in the evaluation of neoplastic and non-neoplastic liver diseases
• Present a logical approach towards the diagnosis of key pancreatibiliary lesions
• Review practical diagnostic “tips” in a variety of gastrointestional tract lesions, including pediatric biopsy specimens.

NOTICE ABOUT OFF-LABEL USE PRESENTATIONS

The Johns Hopkins University School of Medicine/ Johns Hopkins Neuroradiology Review may include presentations on drugs or devices, or use of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. The Johns Hopkins University School of Medicine is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations on off-label uses, does not imply an endorsement by Johns Hopkins of the uses, products, or techniques presented.

COPYRIGHT INFORMATION

All rights reserved. No part of this syllabus may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.